Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nailfold Capillaroscopy in PH: Are Nailfold Changes Reversible With Pulmonary Vasodilator Therapy?

NCT07768644 is registered in ClinicalTrials.gov with University of Glasgow as lead sponsor.

NCT NCT07768644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07768644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nailfold Capillaroscopy in PH: Are Nailfold Changes Reversible With Pulmonary Vasodilator Therapy?
Lead sponsor
University of Glasgow
Phase
Observational
Overall status
Recruiting
Start date
May 20, 2026
Completion date
August 2, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension (pah) (who group 1 ph), pulmonary hypertension (world health organization group 3)